Phase 3 studies showed zasocitinib, a highly selective oral tyrosine kinase 2 inhibitor, provided rapid, durable skin improvement.

TEHRAN, Iran (AP) - Iran closed the Strait of Hormuz again Wednesday in response to Israeli attacks against the Hezbollah ...

On Saturday, June 6, 2026, the Visual Arts Center of New Jersey will celebrate its spring exhibitions with a Community Day ...

Two Phase 3 clinical studies evaluated the efficacy and safety of zasocitinib in patients with moderate to severe plaque psoriasis and found promising results. Approximately 70% of ...

Pearson, a major UK-based education board responsible for setting international GCSE and A-Level exams in over 80 countries, ...